{
    "clinical_study": {
        "@rank": "77414", 
        "biospec_descr": {
            "textblock": "gut microbiome samples from stool, rectal and colonic mucosa"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The purpose if this study is to measure the sensitivity, specificity and accuracy of the\n      Metabiomics Colon Polyp and Colorectal Cancer Assay for the non-invasive detection of colon\n      polyps or colorectal cancer."
        }, 
        "brief_title": "Microbiome Test for the Detection of Colorectal Polyps and Cancer", 
        "completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Colorectal Neoplasms", 
            "Colorectal Cancer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Neoplasms", 
                "Colorectal Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "The purpose of this study is to conduct clinical research to investigate the association of\n      the gut microbiome with colonic neoplasia.  In this study patients will supply samples of\n      their gut microbiome prior to scheduled colonoscopy; the relative abundance of microbes from\n      those samples will be used to predict the presence or absence of colon polyps or colorectal\n      cancer.  Microbiome based predictions from blinded samples will be compared with colonoscopy\n      and pathology results to quantify the sensitivity, specificity and accuracy (reported as %)\n      of the Metabiomics Colon Polyp and Colorectal Cancer Assay for colon polyps.  The limited\n      sample size is anticipated to be insufficient to quantify sensitivity to colorectal cancer."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female,\n\n          -  Age: 45-80 years,\n\n          -  Patients undergoing polyp surveillance or screening colonoscopy who are ASA Class\n             1-3.  No ASA Class 4 or 5 will be included.Footnote\n\n          -  All ethnic and racial groups will be included,\n\n          -  Able to comprehend, sign, and date the written informed consent form (ICF),\n\n          -  Able to give informed consent in English.\n\n        Exclusion Criteria:\n\n          -  History of Inflammatory Bowel Disease\n\n          -  Inability to schedule the colonoscopy within 60 days of the initial stool sample\n\n          -  Colonic pathology that in the opinion of the endoscopist could interfere with the\n             accuracy of the colonoscopy.  Examples include: colonic stricture, poor preparation,\n             obstructing tumor.\n\n          -  ASA class 4 or greater\n\n          -  Vulnerable subjects.  Students, nursing home residents, institutionalized patients,\n             and those with psychological or physical incapacity."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "80 Years", 
            "minimum_age": "45 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients at average risk of developing colorectal cancer, scheduled for colonoscopy."
            }
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 14, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02141945", 
            "org_study_id": "MB-01"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Cancer", 
            "Colorectal Cancer", 
            "Neoplasm", 
            "Colorectal Neoplasm", 
            "Intestinal Neoplasms", 
            "Gastrointestinal Neoplasms", 
            "Digestive System Neoplasms", 
            "Neoplasms by Site", 
            "Neoplasms", 
            "Colonic Diseases", 
            "Digestive System Diseases", 
            "Gastrointestinal Diseases", 
            "Intestinal Diseases", 
            "Rectal Diseases"
        ], 
        "lastchanged_date": "May 15, 2014", 
        "link": {
            "description": "Click here for more information about the sponsor of this study, Metabiomics.", 
            "url": "http://metabiomics.com/"
        }, 
        "location": [
            {
                "contact": {
                    "email": "louis.korman@capitaldigestivecare.com", 
                    "last_name": "Louis Korman, M.D.", 
                    "phone": "301-652-5520"
                }, 
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20006"
                    }, 
                    "name": "DC Endoscopy Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "louis.korman@capitaldigestivecare.com", 
                    "last_name": "Louis Korman, M.D.", 
                    "phone": "301-652-5520"
                }, 
                "facility": {
                    "address": {
                        "city": "Chevy Chase", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "20815"
                    }, 
                    "name": "Chevy Chase Endoscopy Center"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Metabiomics Neoplasia Clinical Research Study", 
        "overall_contact": {
            "email": "louis.korman@capitaldigestivecare.com", 
            "last_name": "Louis Korman, M.D.", 
            "phone": "301 652-5520"
        }, 
        "overall_official": [
            {
                "affiliation": "Metropolitan Gastroenterology Group", 
                "last_name": "Robert Hardi, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Metropolitan Gastroenterology Group", 
                "last_name": "Louis Korman, M.D.", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Microbiome based predictions from at least 100 blinded samples will be compared with colonoscopy and pathology results to quantify the sensitivity, specificity and accuracy (reported as %) of the Metabiomics Colon Polyp and Colorectal Cancer Assay for colon polyps. The limited sample size is anticipated to be insufficient to quantify sensitivity to colorectal cancer.", 
            "measure": "Performance of Metabiomics Colon Polyp and Colorectal Cancer Assay", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02141945"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Metabiomics Corp", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Metabiomics Corp", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}